This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Leland Stanford Junior University. Active years: 2015-2020.
Location History:
- Santa Clara, CA (US) (2015)
- San Francisco, CA (US) (2017 - 2020)
Company Filing History:
Years Active: 2015-2020
Title: Holbrook Kohrt: Innovator in Anti-Tumor Therapy
Introduction
Holbrook Kohrt is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of medical research, particularly in enhancing anti-tumor therapies. With a total of 3 patents to his name, Kohrt is recognized for his innovative approaches to cancer treatment.
Latest Patents
Kohrt's latest patents focus on methods for enhancing the efficacy of antibody therapy directed to tumor cells. These methods aim to improve the effectiveness of existing treatments, providing hope for better outcomes in cancer therapy. His work in this area is crucial for advancing medical science and improving patient care.
Career Highlights
Holbrook Kohrt is affiliated with Leland Stanford Junior University, where he conducts his research and development. His role at the university allows him to collaborate with other experts in the field and contribute to groundbreaking research in oncology.
Collaborations
Some of his notable coworkers include James Torchia and Matthew J Goldstein. Their collaborative efforts enhance the research environment and foster innovation in the fight against cancer.
Conclusion
Holbrook Kohrt's work in developing methods for enhancing anti-tumor antibody therapy showcases his commitment to improving cancer treatment. His contributions to the field are invaluable and continue to inspire future innovations in medical research.